Open Label Extension Study to Evaluate the Safety, Tolerabilityand Cognitive Effects of VEL015 (Sodium Selenate) in Patientswith Alzheimer’s Disease
A Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and the Biological and Cognitive Effects of VEL015 (Sodium Selenate) in Patients with Mild to Moderate Alzheimer’s Disease – a Pilot Study
100 项与 Velacor Therapeutics Pty Ltd. 相关的临床结果
0 项与 Velacor Therapeutics Pty Ltd. 相关的专利(医药)
100 项与 Velacor Therapeutics Pty Ltd. 相关的药物交易
100 项与 Velacor Therapeutics Pty Ltd. 相关的转化医学